Global Markets Direct’s, ‘Secondary Hyperparathyroidism – Pipeline Review, H2 2016’, provides an overview of the Secondary Hyperparathyroidism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Secondary Hyperparathyroidism, complete with analysis by stage of development, drug…